These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Efficacy of thalidomide for treatment of juvenile idiopathic arthritis]. Han TX; Li CF; Wang J; Kuang WY; Zhou YF Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):631-4. PubMed ID: 21849111 [TBL] [Abstract][Full Text] [Related]
5. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. Kimura Y; Fieldston E; Devries-Vandervlugt B; Li S; Imundo L J Rheumatol; 2000 Aug; 27(8):2018-24. PubMed ID: 10955346 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ; Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302 [TBL] [Abstract][Full Text] [Related]
7. Thalidomide in the treatment of refractory rheumatoid arthritis. Keesal N; Wasserman MJ; Bookman A; Lapp V; Weber DA; Keystone EC J Rheumatol; 1999 Nov; 26(11):2344-7. PubMed ID: 10555888 [TBL] [Abstract][Full Text] [Related]
8. [Observations of children with rheumatoid arthritis complicated by amyloidosis treated with immunosuppressive agents]. Rostropowicz-Denisiewicz ; Maldyk E Reumatologia; 1972; 10(1):23-33. PubMed ID: 5019754 [No Abstract] [Full Text] [Related]
9. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study. Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N; Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547 [TBL] [Abstract][Full Text] [Related]
11. Review of medications used in juvenile rheumatoid arthritis. Guthrie B; Rouster-Stevens KA; Reynolds SL Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221 [TBL] [Abstract][Full Text] [Related]
12. Intraarticular triamcinolone in juvenile idiopathic arthritis. Unsal E; Makay B Indian Pediatr; 2008 Dec; 45(12):995-7. PubMed ID: 19129569 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of rheumatoid uveitis in children and teenagers]. Denislam D; Constantin F Oftalmologia; 2005; 49(2):75-81. PubMed ID: 16245748 [TBL] [Abstract][Full Text] [Related]
15. Update on treatment of arthritis in children: new treatments, new goals. Lovell DJ Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494 [TBL] [Abstract][Full Text] [Related]